Evidence map›Paper›PMID 30747701›Full record

ArticleBlood transfusion = Trasfusione del sangue2019

Selective organ ischaemia/reperfusion identifies liver as the key driver of the post-injury plasma metabolome derangements.

Nathan Clendenen, Geoffrey R Nunns, Ernest E Moore, Eduardo Gonzalez, Michael Chapman, Julie A Reisz, Erik Peltz, Miguel Fragoso, Travis Nemkov, Matthew J Wither and 6 more

Open access · greenAbstract read
In one paragraph

Article in Blood transfusion = Trasfusione del sangue, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2022
    Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Nathan ClendenenDepartment of Anesthesiology, University of Colorado Denver, Aurora, CO.
Geoffrey R NunnsDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Ernest E MooreDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Eduardo GonzalezDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Michael ChapmanDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Julie A ReiszDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO.
Erik PeltzDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Miguel FragosoDenver Health Medical Center, Denver, CO.
Travis NemkovDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO.
Matthew J WitherDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO.
Angela SauaiaDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Christopher C SillimanBonfils Blood Center, Denver, CO, United States of America.
Kirk HansenDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO.
Anirban BanerjeeDepartment of Surgery, University of Colorado Denver, Aurora, CO.
Angelo D'AlessandroDepartment of Biochemistry and Molecular Genetics, University of Colorado Denver, Aurora, CO.
Hunter B MooreDepartment of Surgery, University of Colorado Denver, Aurora, CO.
University of Colorado Denver · US

Funding

Analysis and Characterization of Trauma-Induced CoagulopathyUM1HL120877 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI MORRISSEY, JAMES H., WISNIEWSKI, STEPHEN R · 2013 to 2019
$26.6M
Trauma Reprograms CellsP50GM049222 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI BANERJEE, ANIRBAN · 1993 to 2017
$26.1M
Translational Pulmonary Vascular Biology ProgramT32HL007171 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Sonia Castro Flores, Tim Lahm · 1985 to 2026
$9.4M
Mechanisms of Trauma-Induced CoagulopathyT32GM008315 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI Mitchell Cohen, ELIZABETH J. KOVACS · 1991 to 2026
$7.1M
NHLBI NIH HHS T32 HL007171NHLBI NIH HHS UM1 HL120877NIGMS NIH HHS P50 GM049222NIGMS NIH HHS T32 GM008315
6 · The paper itself

Abstract

backgroundUnderstanding the molecular mechanisms in perturbation of the metabolome following ischaemia and reperfusion is critical in developing novel therapeutic strategies to prevent the sequelae of post-injury shock. While the metabolic substrates fueling these alterations have been defined, the relative contribution of specific organs to the systemic metabolic reprogramming secondary to ischaemic or haemorrhagic hypoxia remains unclear. MATERIALS AND

methodsA porcine model of selected organ ischaemia was employed to investigate the relative contribution of liver, kidney, spleen and small bowel ischaemia/reperfusion to the plasma metabolic phenotype, as gleaned through ultra-high performance liquid chromatography-mass spectrometry-based metabolomics.

resultsLiver ischaemia/reperfusion promotes glycaemia, with increases in circulating carboxylic acid anions and purine oxidation metabolites, suggesting that this organ is the dominant contributor to the accumulation of these metabolites in response to ischaemic hypoxia. Succinate, in particular, accumulates selectively in response to the hepatic ischemia, with levels 6.5 times spleen, 8.2 times small bowel, and 6 times renal levels. Similar trends, but lower fold-change increase in comparison to baseline values, were observed upon ischaemia/reperfusion of kidney, spleen and small bowel. DISCUSSION: These observations suggest that the liver may play a critical role in mediating the accumulation of the same metabolites in response to haemorrhagic hypoxia, especially with respect to succinate, a metabolite that has been increasingly implicated in the coagulopathy and pro-inflammatory sequelae of ischaemic and haemorrhagic shock.

Indexed as

MetabolomeAnimalsLiverMaleOxidation-ReductionReperfusion InjurySuccinic AcidSwineSuccinic Acid

Identifiers

PMID30747701
PMCPMC6774928
OpenAlexW2983072204

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.